메뉴 건너뛰기
Drugs
Volumn 52, Issue SUPPL. 1, 1996, Pages 8-14
A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist
Author keywords

[No Author keywords available]
Indexed keywords

ASTEMIZOLE; CAREBASTINE; CIMETIDINE; DRUG METABOLITE; EBASTINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; LEUKOTRIENE C4; LORATADINE; TERFENADINE; THROMBOCYTE ACTIVATING FACTOR;
EID: 0029770651     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600521-00004     Document Type: Review
Times cited : (34)
References (9)
  • 1
    • 0027038162 scopus 로고
    • Fifty years or antihistamine research - From phenbenzamine (RP 2339) to ebastine (RP 64305)
    • Roberts DJ. Fifty years or antihistamine research - from phenbenzamine (RP 2339) to ebastine (RP 64305). Drugs Today 1992; 28 Suppl. B: 1-9
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 1-9
    • Roberts, D.J.1
  • 2
    • 49749156449 scopus 로고
    • Croonian lectures on 'Some chemical factors in the control of the circulation'
    • Dale HH. Croonian lectures on 'Some chemical factors in the control of the circulation'. Lancet 1929; 1: 1179-83, 1233-37, 1285-90
    • (1929) Lancet , vol.1 , pp. 1179-1183
    • Dale, H.H.1
  • 4
    • 0027059348 scopus 로고
    • Preclinical safety studies with ebastine. I. Pharmacological effects on the central nervous system
    • Berga P, Puig J, Fernandez AG, et al. Preclinical safety studies with ebastine. I. Pharmacological effects on the central nervous system. Drugs Today 1992; 28 Suppl. B: 23-7
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 23-27
    • Berga, P.1    Puig, J.2    Fernandez, A.G.3
  • 5
    • 0027062661 scopus 로고
    • Preclinical safety studies with ebastine. II. Pharmacological effects on the cardiovascular system
    • Llenas J, Bou J, Massingham R. Preclinical safety studies with ebastine. II. Pharmacological effects on the cardiovascular system. Drugs Today 1992; 28 Suppl. B: 29-34
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 29-34
    • Llenas, J.1    Bou, J.2    Massingham, R.3
  • 6
    • 9544234987 scopus 로고    scopus 로고
    • Data on file, Laboratorios Almirall
    • Data on file, Laboratorios Almirall
  • 7
    • 0027097588 scopus 로고
    • Preclinical safety studies with ebastine. III. Drug interactions
    • Berga P, Llenas J, Llupia J, et al. Preclinical safety studies with ebastine. III. Drug interactions. Drugs Today 1992; 28 Suppl. B: 35-44
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 35-44
    • Berga, P.1    Llenas, J.2    Llupia, J.3
  • 8
    • 0027070255 scopus 로고
    • Pharmacokinetic studies in rats, dogs and man
    • Martinez-Tobed A, Tarrus E, Segura J, et al. Pharmacokinetic studies in rats, dogs and man. Drugs Today 1992; 28 Suppl. B: 57-67
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 57-67
    • Martinez-Tobed, A.1    Tarrus, E.2    Segura, J.3
  • 9
    • 0027097660 scopus 로고
    • Preclinical safety studies with ebastine. IV. Acute, chronic and reproductive toxicity, mutagenicity and carcinogenicity
    • Jauregui J, Roberts DJ. Preclinical safety studies with ebastine. IV. Acute, chronic and reproductive toxicity, mutagenicity and carcinogenicity. Drugs Today 1992; 28 Suppl. B: 45-56
    • (1992) Drugs Today , vol.28 , Issue.SUPPL. B , pp. 45-56
    • Jauregui, J.1    Roberts, D.J.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.